From idea, to lab, to clinic, to approval—it's a long and expensive process to bring a drug to market. It also rarely ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...

A major new initiative involving Leicester experts aims to redefine human-based research models for greater understanding of ...

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...